Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: Analysis of a contemporary series

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 12, 2015, Pages 503.e17-503.e22

  Liu, Nick W ^a   Shatagopam, Kashyap ^a   Monn, M Francesca ^a   Kaimakliotis, Hristos Z ^a   Cary, Clint ^a   Boris, Ronald S ^a   Mellon, Matthew J ^a   Masterson, Timothy A ^a   Foster, Richard S ^a   Gardner, Thomas A ^a   Bihrle, Richard ^a   House, Michael G ^a   Koch, Michael O ^a  

^a INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

Bladder cancer; Clostridium difficile; Infection; Radical cystectomy; Urinary diversions

Indexed keywords

ALVIMOPAN; ANTACID AGENT; CEFOXITIN; CLOSTRIDIUM TOXIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ABDOMINAL ABSCESS; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIAL GENE; BLADDER CANCER; CANCER SURGERY; CLOSTRIDIUM DIFFICILE INFECTION; CYSTECTOMY; DATA BASE; DEMOGRAPHY; DIARRHEA; DISEASE SEVERITY; DRUG EXPOSURE; FECES ANALYSIS; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PSEUDOMEMBRANOUS COLITIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTICEMIA; SURGICAL MORTALITY; URINARY TRACT INFECTION; URINE CULTURE; URINOMA; WOUND INFECTION; ADVERSE EFFECTS; COMPLICATION; CYTOLOGY; METABOLISM; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; URINARY BLADDER NEOPLASMS;

AGED; CLOSTRIDIUM DIFFICILE; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 85003945915     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.07.007     Document Type: Article

References (30)

1. Polage C.R., Solnick J.V., Cohen S.H. Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis 2012, 55:982.
2. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353:2433.
3. Khanna S., Pardi D.S., Aronson S.L., et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012, 107:89.
4. Gerding D.N., Lessa F.C. The epidemiology of Clostridium difficile infection inside and outside health care institutions. Infect Dis Clin North Am 2015, 29:37-50.
5. See I., Mu Y., Cohen J., et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014, 58:1394.
6. Zerey M., Paton B.L., Lincourt A.E., et al. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt) 2007, 8:557.
7. Krapohl G.L., Morris A.M., Cai S., et al. Preoperative risk factors for postoperative Clostridium difficile infection in colectomy patients. Am J Surg 2013, 205:343.
8. Eyre D.W., Walker A.S., Wyllie D., et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 2012, 55(Suppl. 2):S77.
9. Stevens V., Dumyati G., Fine L.S., et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011, 53:42.
10. Calvert J.K., Holt S.K., Mossanen M., et al. Use and outcomes of extended antibiotic prophylaxis in urological cancer surgery. J Urol 2014, 192:425.
11. Kim S.P., Shah N.D., Karnes R.J., et al. The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. J Urol 2012, 187:2011.
12. Hollenbeck B.K., Taub D.A., Miller D.C., et al. The regionalization of radical cystectomy to specific medical centers. J Urol 2005, 174:1385.
13. Damle R.N., Cherng N.B., Flahive J.M., et al. Clostridium difficile infection after colorectal surgery: a rare but costly complication. J Gastrointest Surg 2014, 18:1804.
14. Large M.C., Kiriluk K.J., DeCastro G.J., et al. The impact of mechanical bowel preparation on postoperative complications for patients undergoing cystectomy and urinary diversion. J Urol 2012, 188:1801.
15. Shah K., Pass L.A., Cox M., et al. Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients. J Trauma Acute Care Surg 2012, 72:691.
16. Keshavamurthy S., Koch C.G., Fraser T.G., et al. Clostridium difficile infection after cardiac surgery: prevalence, morbidity, mortality, and resource utilization. J Thorac Cardiovasc Surg 2014, 148:3157.
17. Hensgens M.P., Goorhuis A., Dekkers O.M., et al. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012, 67:742.
18. Valiquette L., Cossette B., Garant M.P., et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007, 45(Suppl. 2):S112.
19. Muto C.A., Blank M.K., Marsh J.W., et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 2007, 45:1266.
20. Wolf J.S., Bennett C.J., Dmochowski R.R., et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008, 179:1379.
21. Mossanen M., Calvert J.K., Holt S.K., et al. Overuse of antimicrobial prophylaxis in community practice urology. J Urol 2015, 193:543-547.
22. Nazmy M., Yuh B., Kawachi M., et al. Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type. J Urol 2014, 191:681.
23. Bochner B.H., Dalbagni G., Sjoberg D.D., et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol 2015, 67:1042-1050.
24. Nicolle L.E., Bradley S., Colgan R., et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005, 40:643.
25. Eswara J.R., Shariftabrizi A., Sacco D. Positive stone culture is associated with a higher rate of sepsis after endourological procedures. Urolithiasis 2013, 41:411.
26. Herr H.W. Outpatient urological procedures in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria. BJU Int 2012, 110:E658.
27. Herr H.W. The risk of urinary tract infection after flexible cystoscopy in patients with bladder tumor who did not receive prophylactic antibiotics. J Urol 2015, 193:548-551.
28. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431.
29. Lanzas C., Dubberke E.R. Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: a modeling evaluation. Infect Control Hosp Epidemiol 2014, 35:1043.
30. Dial S., Delaney J.A., Barkun A.N., et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. J Am Med Assoc 2005, 294:2989.